Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Revenue

Handa Pharmaceuticals had revenue of 469.90M TWD in the quarter ending June 30, 2025, with 118.02% growth. This brings the company's revenue in the last twelve months to 1.34B, up 37.47% year-over-year. In the year 2024, Handa Pharmaceuticals had annual revenue of 830.67M, down -24.92%.

• Revenue (ttm): 1.34B
• Revenue Growth: +37.47%
• P/S Ratio: 14.83
• Revenue / Employee: n/a
• Employees: 13
• Market Cap: 19.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	830.67M	-275.65M	-24.92%
Dec 31, 2023	1.11B	908.64M	459.66%
Dec 31, 2022	197.68M	168.44M	576.16%
Dec 31, 2021	29.24M	376.00K	1.30%
Dec 31, 2020	28.86M	-55.21M	-65.67%